Brief: Herantis Pharma H2 Net Result Swings To Profit EUR 2.4 Million

Herantis Pharma Oyj

28/02/2019 07:24

Feb 28 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * H2 NET PROFIT EUR 2.4 MILLION VERSUS LOSS EUR 0.1 MILLION
YEAR
AGO
    * DOES NOT EXPECT MEANINGFUL REVENUES IN 2019.
    * MAIN OBJECTIVES FOR 2019 ARE TO PRESENT TOPLINE RESULTS OF
PHASE
1-2 CLINICAL STUDY OF CDNF

Source text for Eikon:  ID:nGNE69YL2Y 
Further company coverage:  HRTIS.HE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))